Literature DB >> 208873

Inhibitory effect of a luteinizing hormone (LH)-releasing hormone agonist on rat ovarian LH and follicle-stimulating hormone receptor levels during pregnancy.

G S Kledzik, L Cusan, C Auclair, P A Kelly, F Labrie.   

Abstract

When injected at the daily dose of 100 microgram on days 7 through 12 of pregnancy, the luteinizing hormone (LH)-releasing hormone (LHRH) agonist [D-Ala6, des-Gly-NH2(10)] LHRH ethylamide led to complete suppression of pregnancy and a 45% to 60% decrease in plasma progesterone concentration. The antifertility effect of the LHRH analog was accompanied by an early and almost complete inhibition of ovarian LH/human chorionic gonadotropin and follicle-stimulating hormone receptor levels. These data suggest that the antifertility effects of LHRH agonists are mediated by down-regulation of ovarian gonadotropin receptors and decreased luteal function.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 208873     DOI: 10.1016/s0015-0282(16)43286-3

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  2 in total

1.  Similar luteinizing hormone-releasing hormone binding sites in rat anterior pituitary and ovary.

Authors:  J J Reeves; C Séguin; F A Lefebvre; P A Kelly; F Labrie
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

2.  Effect of chronic treatment with [D-Ala6, des-Gly-NH210]LHRH ethylamide on ovarian histology in the rat.

Authors:  C Séguin; G Pelletier; F Labrie
Journal:  Cell Tissue Res       Date:  1982       Impact factor: 5.249

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.